Keith L. Knutson,Mary L. Disis,John D. Fikes,Melanie Beebe,Glenn Ishioka
申请号：
US15381454
公开号：
US20170342126A1
申请日:
2016.12.16
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention provides HLA-DR (MHC class II) binding peptides derived from the ovarian/breast cancer associated antigens, Human Epidermal Growth Factor Receptor 2 (HER-2/neu), Carcinoembryonic Antigen (CEA), Insulin Growth Factor Binding Protein 2 (IGFBP-2), and Cyclin D1. The immunogenic peptides can be used in cancer vaccines.
